Canada Negotiates Drug Prices w Pan-Canadian Consortium Sunitinib & Pazopanib are most commonly prescribed off trial settings - 100098

Spotlight
Video

Canada Negotiates Drug Prices w Pan-Canadian Consortium Sunitinib & Pazopanib are most commonly prescribed off trial settings

kidneycancer has 473 videos Subscribe Here

Loading........
Description: Aly-Khan Lalani, MD Dana Farber Cancer Institute, discusses Canada Negotiates Drug Prices w Pan-Canadian Consortium Sunitinib & Pazopanib are most commonly prescribed off trial settings at Kidney Cancer Association 2017 in Miami.
Shared By : kidneycancer
Posted on : 02/22/18
Added : 4 months ago
Category : Kidney Cancer



Recommended

Nothing found.